FIELD: medicine.
SUBSTANCE: invention relates to compounds of general formula I which can be used as a carrier in drug delivery systems or for the indication of antibodies. In formula I, Y is O, NH or a covalent bond, P1 is H, straight or branched alkyl which contains from 1 to 12 carbon atoms optionally substituted with an amide group, additionally substituted with alkoxyaryl, P2, P3 are independently of each other H, alkoxycarbonyl, optionally substituted with fluorenyl, or polyoxy(C2-C3)alkylene substituted with an amino group and a -CO- group, L is a group of formula (a), in which the dashed line is the point of attachment to N, R1 is H, R1' is H, R2 is H, R2' is H or a group of formula -ORd or -CH2-ORd, R3 is H or a group of formula -(CH2)2-ORe or -(CH2)3-ORe, Ra, Rd, Re are independently of each other a saturated or unsaturated, straight or branched hydrocarbon chain which contains from 6 to 30 carbon atoms, m is 1, 2 or 3, provided that at least one of R1, R1', R2, R2', R3 is not H. Invention also relates to a vesicular composition and a kit for use in a drug delivery system, said drug comprising a compound of formula I.
I, (a).
EFFECT: amino acid lipids are disclosed.
13 cl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
TARGETING AMINOACID LIPIDS | 2013 |
|
RU2654210C2 |
NOVEL SURFACTANTS AND USE THEREOF | 2004 |
|
RU2395493C2 |
FUSOGENIC COMPOUNDS FOR DELIVERY OF BIOLOGICALLY ACTIVE MOLECULES | 2018 |
|
RU2808990C2 |
PEPTIDES INHIBITING NEURON EXOCYTOSIS | 2007 |
|
RU2461568C2 |
STEROIDS THAT RELEASE NITROGEN OXIDE | 2008 |
|
RU2442790C2 |
DERIVATIVES OF PROPANOLAMINE JOINED WITH BILE ACIDS, MEDICINAL AGENT | 1999 |
|
RU2234512C2 |
METHOD FOR STRUCTURAL AND/OR FUNCTIONAL IMPROVEMENT OF ARTERIOLES | 2005 |
|
RU2414236C2 |
3-AMINOALKYL-1,4-DIAZEPAN-2-ONE MELANOCORTIN-5 RECEPTOR ANTAGONISTS | 2009 |
|
RU2530017C2 |
LIPIDS FOR THERAPEUTIC AGENT DELIVERY FORMULATIONS | 2013 |
|
RU2658007C2 |
NOVEL LIPID COMPOUNDS | 2007 |
|
RU2509071C2 |
Authors
Dates
2018-10-24—Published
2013-03-11—Filed